GRAIL, NCT01335932: Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure |
|
|
| Completed | 2 | 160 | US | IV Ganciclovir, Placebo | Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), Genentech, Inc. | Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure | 06/16 | 10/16 | | |